resveratrol has been researched along with Stroke in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (22.22) | 29.6817 |
2010's | 28 (62.22) | 24.3611 |
2020's | 7 (15.56) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Chen, Q; Guo, C; Guo, H; Kaihang, M; Su, Y; Wang, J | 1 |
Chen, Y; Huang, J; Li, X; Liao, H; Liu, J; Wen, J; Yang, Q; Zhu, H | 1 |
Burguete, MC; Castelló-Ruiz, M; Hervás, D; López-Morales, MA; Pérez-Pinzón, MA; Salom, JB | 1 |
Jha, S; Prakash Babu, P; Teertam, SK | 1 |
Ding, D; Dong, J; Li, X; Lu, X; Xu, H; Zheng, D | 1 |
Cui, JZ; Cui, Y; Liu, JJ; Wang, KJ; Zhang, WQ | 1 |
Carter, A; Comin, CH; Corbett, D; Issa, L; Jasmin, BJ; Jeffers, MS; Kuhl, LM; Lacoste, B; McDonald, MW; Morse, C; Ripley, A | 1 |
Cohan, CH; Dave, KR; Khoury, N; Koronowski, KB; Loris, ZB; Perez-Pinzon, MA; Saul, I; Stradecki-Cohan, HM; Young, JI | 1 |
Arranz, S; Eder, M; Tressera-Rimbau, A; Vallverdú-Queralt, A | 1 |
Annunziato, L; Benarese, M; Cepparulo, P; Cuomo, O; Faggi, L; Lanzillotta, A; Mota, M; Parrella, E; Pignataro, G; Pizzi, M; Porrini, V; Spano, P; Tonin, P; Vinciguerra, A | 1 |
Abdel-Daim, MM; Bungau, S; Bustea, C; Endres, L; Fodor, K; Iovan, C; Pasca, B; Tit, DM; Uivarosan, D | 1 |
Dou, Z; Lv, Y; Rong, X; Zhang, L; Zhao, E | 1 |
Barber, PA; Chen, ZY; Cui, M; Luo, WJ; Wang, LM; Wang, XJ; Wang, YJ | 1 |
Ballesteros, I; Camarero, G; Cuartero, MI; Hernández-Jiménez, M; Hurtado, O; Lizasoain, I; Moraga, A; Moro, MA; Pradillo, JM; Zarruk, JG | 1 |
Agrawal, M; Doré, S; Singh, N | 1 |
Abd-El-Aziz, AS; Connell, BJ; Khan, BV; Kucukkaya, I; Rajagopal, D; Saleh, MC; Saleh, TM | 1 |
Ducruet, AF; Weiner, GM | 1 |
El-Remessy, AB; Ergul, A; Fagan, SC; Fouda, AY; Ishrat, T; Mohamed, IN; Pillai, B; Soliman, S | 1 |
Gim, SA; Kim, MO; Koh, PO; Shah, FA | 1 |
Daglia, M; Li, H; Nabavi, SF; Nabavi, SM | 1 |
Chiba, T; Itoh, T; Suzuki, S; Umegaki, K; Yokotani, K | 1 |
Cao, L; Chen, L; Ding, L; Lv, W; Pan, J; Pang, C; Wang, G; Wang, L; Wang, W; Wu, F; Xu, Y; Yu, Y; Zhang, H; Zhang, M; Zhu, J | 1 |
Dempsey, RJ; Lopez, MS; Vemuganti, R | 1 |
Bosche, B; Caglayan, AB; Doeppner, TR; Hermann, DM; Kaltwasser, B; Kilic, E; Zechariah, A | 1 |
Bai, Q; Chen, J; Sui, H; Xie, X; Zhao, Z | 1 |
Agrawal, M | 1 |
Chen, J; Jia, W; Song, X; Tang, F; Wang, L; Yang, Q; Yu, P; Zeng, L; Zhou, L | 1 |
Hou, R; Hou, Y; Wan, D; Wang, K; Ye, X; Zhou, Y | 1 |
Cocks, G; Dias, GP; do Nascimento Bevilaqua, MC; Nardi, AE; Thuret, S | 1 |
Cho, S; Jeong, SI; Kang, JL; Kim, HW; Lee, JY; Park, EM; Shin, JA | 1 |
Dong, W; Gao, D; Li, F; Li, N; Zhang, X; Zhen, H | 1 |
Simonyi, A; Sun, AY; Sun, GY; Wang, Q | 1 |
Choi, JH; Koh, Y; Lee, H; Lim, YK; Park, EM; Shin, JA | 1 |
Wu, Y; Zhang, F | 1 |
Guo, S; Leung, W; Lo, EH; Lok, J; Navaratna, D; Pagnussat, AS; Salbego, CG; Seo, JH; Simão, F; Waeber, C | 1 |
Barber, PA; Bari, F; Busija, DW; Clark, D; Institoris, A; Kinniburgh, DW; Kulynych, A; Thompson, R; Tuor, UI; Zhang, X | 1 |
Frank, GC | 1 |
Inoue, H; Jiang, XF; Katayama, T; Namura, S; Osada, S; Umesono, K | 1 |
Szmitko, PE; Verma, S | 1 |
Cheng, G; Gao, D; Huang, W; Jiang, X; Peng, Y; Song, L; Zhang, X | 1 |
Baur, JA; Sinclair, DA | 1 |
Dong, W; Gao, D; Zhang, X | 1 |
Ikeda, K; Mizutani, K; Yamori, Y | 1 |
Ikeda, K; Mizutani, K; Nishikata, T; Yamori, Y | 1 |
Chaudhary, G; Gupta, YK; Sinha, K | 1 |
10 review(s) available for resveratrol and Stroke
Article | Year |
---|---|
Effect and mechanisms of resveratrol in animal models of ischemic stroke: A systematic review and Bayesian meta-analysis.
Topics: Animals; Bayes Theorem; Disease Models, Animal; Ischemic Stroke; Mice; Rats; Resveratrol; Stroke | 2023 |
Dietary Polyphenols in the Prevention of Stroke.
Topics: Animals; Diet; Humans; Nitric Oxide; Oxidative Stress; Oxidoreductases; Polyphenols; Protective Agents; Quercetin; Resveratrol; Stilbenes; Stroke | 2017 |
Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biological Availability; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Gerbillinae; Humans; Mice; Neuroprotective Agents; Oxidative Stress; Rats; Resveratrol; Stilbenes; Stroke | 2013 |
Resveratrol and stroke: from chemistry to medicine.
Topics: Animals; Antioxidants; Biological Availability; Humans; Resveratrol; Stilbenes; Stroke | 2014 |
Resveratrol neuroprotection in stroke and traumatic CNS injury.
Topics: Animals; Antioxidants; Brain Injuries; Humans; Neuroprotection; Neuroprotective Agents; Resveratrol; Stilbenes; Stroke | 2015 |
Natural polyphenols based new therapeutic avenues for advanced biomedical applications.
Topics: Aging; Animals; Anti-Infective Agents; Antioxidants; Catechin; Food Hypersensitivity; Humans; Models, Biological; Neoplasms; Polyphenols; Renal Insufficiency; Resveratrol; Stilbenes; Stroke | 2015 |
Resveratrol: A Potential Hippocampal Plasticity Enhancer.
Topics: Aging; Animals; Disease Models, Animal; Fatigue; Hippocampus; Neurogenesis; Neuronal Plasticity; Resveratrol; Stilbenes; Stress, Physiological; Stroke | 2016 |
Resveratrol as a therapeutic agent for neurodegenerative diseases.
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Antioxidants; Cell Death; Humans; Inflammation; Neurodegenerative Diseases; Neuroglia; Neurons; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Resveratrol; Stilbenes; Stroke | 2010 |
From sandwiches to center stage. Peanuts pack a powerful nutritional punch.
Topics: Arachis; Coronary Disease; Fatty Acids, Monounsaturated; Health Promotion; Humans; Menu Planning; Neoplasms; Phytosterols; Resveratrol; Stilbenes; Stroke | 2003 |
Therapeutic potential of resveratrol: the in vivo evidence.
Topics: Aging; Animals; Heart Diseases; Humans; Inflammation; Myocardial Infarction; Neoplasms; Protective Agents; Resveratrol; Stilbenes; Stroke | 2006 |
1 trial(s) available for resveratrol and Stroke
Article | Year |
---|---|
Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.
Topics: Aged; Antioxidants; Female; Fibrinolytic Agents; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Resveratrol; Stilbenes; Stroke; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2016 |
34 other study(ies) available for resveratrol and Stroke
Article | Year |
---|---|
Novel multifunctional bionanoparticles modified with sialic acid for stroke treatment.
Topics: Curcumin; Humans; N-Acetylneuraminic Acid; Nanoparticles; Oxidative Stress; Polysaccharides; Reperfusion Injury; Resveratrol; Stroke | 2022 |
Sirt1 regulates microglial activation and inflammation following oxygen-glucose deprivation/reoxygenation injury by targeting the Shh/Gli-1 signaling pathway.
Topics: Glucose; Hedgehog Proteins; Humans; Inflammation; Microglia; Oxygen; Resveratrol; Signal Transduction; Sirtuin 1; Stroke; Zinc Finger Protein GLI1 | 2023 |
Up-regulation of Sirt1/miR-149-5p signaling may play a role in resveratrol induced protection against ischemia via p53 in rat brain.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Cell Survival; Infarction, Middle Cerebral Artery; Male; MicroRNAs; Rats; Resveratrol; Signal Transduction; Sirtuin 1; Stroke; Tumor Suppressor Protein p53; Up-Regulation | 2020 |
Reperfusion combined with intraarterial administration of resveratrol-loaded nanoparticles improved cerebral ischemia-reperfusion injury in rats.
Topics: Animals; Antioxidants; Brain Ischemia; Brain-Derived Neurotrophic Factor; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Male; Nanoparticles; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stroke | 2020 |
Piceatannol protects against cerebral ischemia/reperfusion‑induced apoptosis and oxidative stress via the Sirt1/FoxO1 signaling pathway.
Topics: Animals; Antioxidants; Apoptosis; Brain Ischemia; Caspase 3; Forkhead Box Protein O1; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Reperfusion Injury; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Stroke | 2020 |
An Exercise Mimetic Approach to Reduce Poststroke Deconditioning and Enhance Stroke Recovery.
Topics: Animals; Antioxidants; Behavior, Animal; Cardiovascular Deconditioning; Combined Modality Therapy; Disease Models, Animal; Female; Hindlimb; Muscle, Skeletal; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Recovery of Function; Resistance Training; Resveratrol; Sensorimotor Cortex; Stroke; Stroke Rehabilitation | 2021 |
Neuronal SIRT1 (Silent Information Regulator 2 Homologue 1) Regulates Glycolysis and Mediates Resveratrol-Induced Ischemic Tolerance.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Glycolysis; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Resveratrol; Sirtuin 1; Stilbenes; Stroke | 2017 |
Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.
Topics: Acetylation; Animals; Bcl-2-Like Protein 11; Disease Models, Animal; Drug Synergism; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Promoter Regions, Genetic; Protein Binding; Resveratrol; Stilbenes; Stroke; Transcription Factor RelA; Valproic Acid | 2018 |
Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dietary Supplements; Female; Humans; Male; Resveratrol; Stilbenes; Stroke | 2018 |
Neuroprotection of Resveratrol Against Focal Cerebral Ischemia/Reperfusion Injury in Mice Through a Mechanism Targeting Gut-Brain Axis.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Capillary Permeability; Cytokines; Epithelial Cells; Gastrointestinal Tract; Inflammation; Intestine, Small; Male; Mice, Inbred C57BL; Models, Biological; Neuroprotection; Reperfusion Injury; Resveratrol; Stroke; T-Lymphocytes, Helper-Inducer | 2019 |
A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia.
Topics: Age Factors; AMP-Activated Protein Kinases; Animals; Cerebral Cortex; Diet; Energy Metabolism; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; NAD; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Stilbenes; Stroke | 2013 |
Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Blotting, Western; Brain Ischemia; Cells, Cultured; Cytidine Diphosphate Choline; Drug Synergism; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Knockout; Monocytes; Naphthols; Neurons; Neuroprotective Agents; Nootropic Agents; Rats; Rats, Inbred F344; Resveratrol; Sirtuin 1; Stilbenes; Stroke | 2013 |
Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances neuroprotection in a rat model of ischemia/reperfusion.
Topics: Animals; Antioxidants; Brain Ischemia; Disease Models, Animal; Humans; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes; Stroke; Thioctic Acid | 2014 |
Resveratrol and pharmacological potentiation in ischemic stroke.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Humans; Resveratrol; Stilbenes; Stroke; Treatment Outcome | 2014 |
Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice.
Topics: Animals; Carrier Proteins; Drug Delivery Systems; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Resveratrol; Stilbenes; Stroke; Thioredoxins; Thromboembolism | 2015 |
Proteomic identification of proteins differentially expressed in response to resveratrol treatment in middle cerebral artery occlusion stroke model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Proteomics; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stroke; Transcriptome | 2014 |
Resveratrol Partially Suppresses Inflammatory Events but Does not Affect Stroke Onset in Stroke-Prone Spontaneously Hypertensive Rats.
Topics: Adenylate Kinase; Animals; Antioxidants; Blood Glucose; Blood Pressure; Body Weight; Cerebrovascular Circulation; Chemokine CCL2; Endothelial Cells; Inflammation; Interleukin-1beta; Male; Rats; Rats, Inbred SHR; Resveratrol; Signal Transduction; Stilbenes; Stroke | 2015 |
The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis.
Topics: Animals; Antidepressive Agents; Brain Ischemia; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Frontal Lobe; Hypothalamo-Hypophyseal System; Imipramine; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Pituitary-Adrenal System; Random Allocation; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stroke | 2015 |
Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemia.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Neurogenesis; Neurons; Oxidative Stress; Recovery of Function; Resveratrol; Rotarod Performance Test; Signal Transduction; Sirtuin 1; Stilbenes; Stroke | 2015 |
Resveratrol Pretreatment Decreases Ischemic Injury and Improves Neurological Function Via Sonic Hedgehog Signaling After Stroke in Rats.
Topics: Animals; Animals, Newborn; Antioxidants; Brain Ischemia; Female; Hedgehog Proteins; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Resveratrol; Signal Transduction; Stilbenes; Stroke; Treatment Outcome | 2017 |
Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Brain; Brain Infarction; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Male; Neuroprotective Agents; Phosphoric Diester Hydrolases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Rolipram; Signal Transduction; Sirtuin 1; Stilbenes; Stroke | 2016 |
Resveratrol attenuates peripheral and brain inflammation and reduces ischemic brain injury in aged female mice.
Topics: Adipocytes; Animals; Brain; Brain Ischemia; Encephalitis; Female; Humans; Immunoglobulin G; Inflammation; Interleukin-1beta; Intra-Abdominal Fat; Mice, Inbred C57BL; Postmenopause; Resveratrol; Stilbenes; Stroke; Tumor Necrosis Factor-alpha | 2016 |
Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Topics: Angiogenic Proteins; Animals; Blotting, Western; Brain; Coloring Agents; Disease Models, Animal; Drug Administration Schedule; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Microcirculation; Motor Activity; Neovascularization, Physiologic; Neuroprotective Agents; Reperfusion Injury; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Stroke; Tetrazolium Salts; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A | 2008 |
Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke.
Topics: Acute Disease; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Immunologic; Female; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Reactive Oxygen Species; Resveratrol; Stilbenes; Stroke | 2010 |
Resveratrol may be an effective prophylactic agent for ischemic stroke.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Brain Ischemia; Coronary Disease; Cyclooxygenase Inhibitors; Free Radical Scavengers; Humans; Neuroprotective Agents; Nitric Oxide; Resveratrol; Stilbenes; Stroke; Wine | 2011 |
Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases.
Topics: Angiogenesis Inducing Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Brain; Cadherins; Endothelial Cells; Humans; MAP Kinase Signaling System; Metalloproteases; Nitric Oxide; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; Stroke; Vascular Endothelial Growth Factor A | 2012 |
Protection against recurrent stroke with resveratrol: endothelial protection.
Topics: Administration, Oral; Animals; Biomarkers; Blood Gas Analysis; Blood Pressure; Blood-Brain Barrier; Body Temperature; Brain; Cell Death; Cell Hypoxia; Cerebrovascular Circulation; Endothelial Cells; Endothelium, Vascular; Glucose; Heart Rate; Inflammation; Liver; Nitrosation; Oxidation-Reduction; Oxygen; Rats; Recurrence; Resveratrol; Stilbenes; Stress, Physiological; Stroke; Treatment Outcome | 2012 |
Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.
Topics: Animals; Brain; Cattle; Dose-Response Relationship, Drug; Fenofibrate; Haplorhini; Humans; Mice; Mice, Knockout; Receptors, Cytoplasmic and Nuclear; Resveratrol; Stilbenes; Stroke; Transcription Factors | 2003 |
Cardiology patient pages. Red wine and your heart.
Topics: Alcohol Drinking; Animals; Antioxidants; Arteriosclerosis; Cohort Studies; Cricetinae; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Flavonoids; Follow-Up Studies; Gene Expression Regulation; Humans; Male; Middle Aged; Myocardial Infarction; Phenols; Phytotherapy; Polyphenols; Rabbits; Resveratrol; Risk; Stilbenes; Stroke; Wine | 2005 |
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cerebral Cortex; Disease Models, Animal; Gene Expression; Ischemic Attack, Transient; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Reperfusion Injury; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Stroke | 2006 |
Mitochondria biogenesis induced by resveratrol against brain ischemic stroke.
Topics: Animals; Antioxidants; Brain Ischemia; DNA, Mitochondrial; Flavonoids; Humans; Hypoxia; Mice; Mitochondria; Models, Biological; Phenols; Polyphenols; Reactive Oxygen Species; Reperfusion Injury; Resveratrol; Stilbenes; Stroke | 2007 |
Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cells, Cultured; Collagen; DNA; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fulvestrant; Glycation End Products, Advanced; Male; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Procollagen-Proline Dioxygenase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Estrogen; Resveratrol; Stilbenes; Stroke; Time Factors; Transforming Growth Factor beta | 2000 |
Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
Topics: Animals; Base Sequence; Cells, Cultured; DNA Damage; DNA Primers; Estrogens, Non-Steroidal; Genistein; Glutathione; Glutathione Peroxidase; Glycation End Products, Advanced; Hypertension; Isoflavones; Muscle, Smooth, Vascular; Oxidation-Reduction; Oxidative Stress; Phytoestrogens; Plant Preparations; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Stilbenes; Stroke | 2000 |
Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats.
Topics: Animals; Brain; Disease Models, Animal; Drug Administration Schedule; Free Radicals; Hand Strength; Ischemic Attack, Transient; Male; Malondialdehyde; Middle Cerebral Artery; Motor Activity; Muscle, Skeletal; Oxidative Stress; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Reference Values; Reperfusion Injury; Resveratrol; Stilbenes; Stroke; Time Factors | 2002 |